🟢 Lantern Pharma is trading 6.38% up in pre-market with no new company announcement identified

Lantern Pharma is trading at $0.66, up 6.38%, with no new company announcement identified for October 27.

• Its investor-relations page lists the latest releases as October 8 and earlier.
• The latest company-specific developments found—a Taiwan trial approval on October 7 and a conference presentation announced October 8—predate the move.
• Broader-market indicators are modestly positive, but available evidence does not establish them as the cause. No volume or activity data was provided.